Mill Creek Capital Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1964962 Conshohocken, PA

Position in ABBV

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$396,049

-$13,405 QoQ

Shares Held

1,821

+1.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Mill Creek Capital Advisors, LLC holds $59,193,747 across 6 Drug Manufacturers - General names. ABBV ranks #5 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	227,635	$55,643,099
2	AMGN	Amgen Inc	4,238	$1,491,140
3	MRK	Merck & Co., Inc.	5,935	$713,921
4	LLY	ELI LILLY & Co	614	$564,738
5	ABBV	AbbVie Inc. This page	1,821	$396,049
6	GILD	Gilead Sciences, Inc.	2,761	$384,800

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$396,049	1,821	+1.6%	Shares	Sole	2026-05-14
2025-12-31	$409,454	1,792	-28.2%	Shares	Sole	2026-02-13
2025-09-30	$577,692	2,495	+21.1%	Shares	Sole	2025-11-12
2025-06-30	$382,377	2,060	-36.4%	Shares	Sole	2025-08-11
2025-03-31	$678,425	3,238	+3.6%	Shares	Sole	2025-05-13
2024-12-31	$555,490	3,126	-4.3%	Shares	Sole	2025-01-29
2024-09-30	$645,167	3,267	-12.6%	Shares	Sole	2024-11-06
2024-06-30	$640,970	3,737	+9.2%	Shares	Sole	2024-08-14
2024-03-31	$622,964	3,421	-12.7%	Shares	Sole	2024-05-14
2023-12-31	$607,172	3,918	+0.9%	Shares	Sole	2024-02-14
2023-09-30	$578,949	3,884	-24.1%	Shares	Sole	2023-11-14
2023-06-30	$689,548	5,118	+23.9%	Shares	Sole	2023-08-14
2023-03-31	$658,357	4,131	-3.9%	Shares	Sole	2023-05-15
2022-12-31	$694,761	4,299	—	Shares	Sole	2023-05-25
No filing history on record for this holder in this stock.